Trial intelligence / Profile preview

Immune Status Prediction of Metformin Efficacy in PCOS

NCT06325956Recruiting

Sponsor
Shanghai Tenth People's Hospital
Start
Mar 2024
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of metformin in polycystic ovary syndrome (PCOS), sponsored by Shanghai Tenth People's Hospital. Primary endpoints: Number of cell groups expressing different markers and Percentage of cell groups expressing different markers. Started Mar 2024; status: recruiting.

02

Drugs

metformin
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT06325956.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06325956.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call